Covid19 Impact on HLA Typing Market

-

 Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research.

The global HLA typing market is projected to reach USD 1.7 billion by 2025 from USD 1.2 billion in 2019, at a CAGR of 5.9%. However, the high costs of HLA typing products and limited reimbursements for target procedures are expected to restrain market growth in the coming years. Along with this, the significant supply-demand gap between the number of organ donors and organs required annually is expected to challenge market growth to a certain extent.

By product and service, reagents & consumables accounted for the largest market share in 2019.

On the basis of product & service, the HLA typing market has been segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the HLA typing market in 2019. The segment is expected to register the highest growth in the same year. Factors such as the growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets are driving the growth of this segment.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39129877

Based on technology, the molecular assay technologies segment accounted for the largest share in 2019.

On the basis of technology, the HLA typing market is segmented into molecular and non-molecular assay technologies. The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019. The growth of this segment is attributed to their benefits over non-molecular assays, such as low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis.

The diagnostic applications segment will continue to dominate the HLA typing market in 2025.

On the basis of application, the market is segmented into diagnostic and research applications. The diagnostic applications segment dominated the HLA typing market in 2018. This is attributed to technological advancements in molecular assay techniques, the increasing adoption of molecular assay procedures for pathogen encounter detection and histocompatibility cross-matching, and the growing incidence of chronic and infectious diseases.

The commercial service providers segment accounted for the largest share of the HLA typing market in 2019.

On the basis of end user, the market is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the HLA typing market due to the rapid modernization and adoption of automation in HLA typing, growing outsourcing of R&D activities to said providers, and the increasing consolidation of diagnostic laboratories.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=39129877

The market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage in several APAC countries.

Leading Companies

Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Immucor, Inc. (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), GenDx (Netherlands), and Biofortuna (UK) are the players in this market.

Comments

Post a Comment

If you have any issue, Let me know ?

Popular posts from this blog

Laboratory Balances and Scales Market by Product (Balances (Analytical, Precision, Micro, Portable, Moisture) - Global Forecast to 2023

-
Image
According to the new market research report  " Laboratory Balances and Scales Market  by Product (Balances (Analytical, Precision, Micro, Portable, Moisture), Scales (Bench, Counting, Compact)), End User (Pharmaceutical, Biotechnology, Chemical, Beverage, Petroleum, Academia) - Global Forecast to 2023" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The major factors driving the growth of the laboratory balances and scales market are the technological advancements in laboratory balances and scales; increasing research investments and activities among pharma-biotech companies and CROs; increasingly stringent regulatory framework for product safety in bio-pharmaceutical industries; implementation of stringent food safety guidelines; and emerging markets. Based on product type, the laboratory balances market is segmented into m...
Read more

New Approach towards Technological Advancements in Ligation Devices Market

-
Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Ligation Devices Market Growth The  Global ligation devices market  is projected to reach $1,189 million by 2024 from $876 million in 2019, at a CAGR of 6.3%. Download PDF Brochures –  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22007372 Accessories – Ligation Devices The market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets. Applications – Ligation Devices The market is segmented into gastrointestinal & abdominal surgeries...
Read more

Medical Holography Market is Future of Healthcare, it is Creating Real Change in the Healthcare Industry

-
According to a new market research report “ Medical Holography Market  by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021 ” published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021. The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures. In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region. Based on product type, the market is segmented into holographic displays, holography microscopes, holo...
Read more